Remepy Raises $36M Series A to Advance Hybridopa Into Phase III

Remepy has raised $36 million in Series A financing to advance its lead Parkinson’s disease program into a global Phase... Read More

The post Remepy Raises $36M Series A to Advance Hybridopa Into Phase III appeared first on citybiz.